Comparison of β-Lactam and Non–β-Lactam Antibiotic Prophylaxis in Elective Colorectal Surgical Procedures - Takeaways - MDSpire

Comparison of β-Lactam and Non–β-Lactam Antibiotic Prophylaxis in Elective Colorectal Surgical Procedures

  • By

  • Curtis D. Collins

  • Eric Hartsfield

  • Robert K. Cleary

  • Michael P. Veve

  • Kara K. Brockhaus

  • April 13, 2026

  • 0 min

Share

  • 1

    Surgical site infections (SSIs) significantly increase patient morbidity and healthcare costs, totaling up to $10 billion annually.

  • 2

    β-Lactam antibiotics are preferred for surgical prophylaxis due to their efficacy, safety, and cost-effectiveness compared to non–β-lactam alternatives.

  • 3

    Patients with documented β-lactam allergies often receive non–β-lactam alternatives, which may lead to higher SSI rates despite concerns about cross-reactivity.

  • 4

    This study aims to compare the incidence of 30-day SSIs between β-lactam and non–β-lactam prophylaxis in elective colorectal surgeries, controlling for dosing and timing.

  • 5

    Data for this multicenter study were sourced from the Michigan Surgical Quality Collaborative, ensuring reliability through standardized definitions and audits.

Original Source(s)

Related Content